Atlas
Market PulseMovers & ShakersSector ViewStocksETFFundsPortfoliosAdmin
Atlas › Stocks › HCG

HCG

Healthcare Global Enterprises Limited
Micro-capHealthcare ↗

What the six lenses say about HCG — its relative strength vs the baselines, price & RS trend, the 8-quarter financials, and live filings.

Price
₹687.9
2026-09-08
VWAP · 1Y anchor
₹656
+4.8% from VWAP
P/E · TTM
739.7×
TTM EPS ₹0.9
52-week range
67%
position low→high
RSI(14)
45
momentum

Own sector index

Healthcare ↗
Neutral

1M

-1.1%

3M

+7.1%

1Y

+14.5%

Breadth >EMA21

55%

How HCG’s own sector index is moving — context for reading the stock’s six lenses.

Six-lens read

What the six lenses say

How the lenses are scored ↗
Strength
7.5
avg conviction decile
Leadership
—
top-decile composite in cohort
Each lens is a decile within its cap cohort (D10 = top 10%) — no black-box composite. Expand a lens for the real numbers behind it.
LensDecile · Micro-cap cohortDRaw
TechnicalD788›

The actual numbers

Price vs VWAP (1y)+4.8%
EMA trend stackUp · 21>50>200
Price vs 200-EMA+7.5%
Price vs 50-EMA+0.3%
RSI(14)45
RS vs Nifty 500 · 3M+5.1%
RS vs sector · 3M+2.4%
52-week range67%
Volume vs 30d avg0.85×
Volume vs 60d avg0.75×
ATR(14) · volatility28.2
Bollinger width · vol contraction0.088
FundamentalD222›

The actual numbers

Return on equity (ROE)1.7%
Operating margin8.0%
Net margin0.9%
Revenue growth · YoY+14.6%
EPS growth · YoY-70.6%
Debt / equity1.30×

Full 8-quarter history in the financials table below.

ValuationD25›

The actual numbers

P/E (TTM)739.7×
TTM EPS₹0.9
52-week range67%
CatalystD640›

The actual numbers

Earnings & momentum38
Capital actions16
Governance103

Every filing in the corporate-announcements panel below.

FlowD858›

The actual numbers

Promoter holding64.2%
Delivery · 30d avg56.7%
Up/down-day asymmetry3.7pp
How the decile & conviction are calculated

Decile — each lens’s 0–100 score is ranked against every Micro-cap stock in the universe. D10 = top 10% (strongest), D1 = bottom 10%. A decile is simply where this stock sits versus its size-peers on that lens — no weighting, no black box.

Conviction — the average of the two active conviction-lens deciles (Technical & Flow):

( D7 + D8 ) ÷ 2 = 7.5(Technical · Flow)

Fundamental, Catalyst, Valuation and Policy are shown for context but carry weight 0 in the current model, so they are not scored into conviction. Full detail on the methodology page ↗.

Glass box

How the score is built

Click a lens to expand its sub-components, then drill to the actual values. The eye icon on any term explains it.

Conviction score · Highest
85
Conviction score 85/100 · avg-decile strength 7.5/10
Conviction score85/100›
TechnicalD7›
FundamentalD2›
ValuationD2›
CatalystD6›
FlowD8›

Policy

Government policy · Healthcare

Active policies relevant to this sector — flagged as a Red / Amber / Green signal, not scored into the six-lens conviction. The lenses say what the market is doing; policy is context for why.

Tailwind· HIGH impact

PLI Scheme — Pharmaceuticals & API

Production-linked incentive scheme for pharmaceuticals, APIs, and medical devices

Relative strength · always on

Percentage-point spread vs each baseline across six windows. Green = outperforming, red = lagging. Data as of 2026-09-08.

Baseline1D1W1M3M6M12M
Nifty 50
Large-cap anchor
-1.3pp
-4.9pp
+4.9pp
+6.7pp
+26.6pp
+3.7pp
Nifty 500
Broad-market baseline
-1.3pp
-4.9pp
+3.8pp
+5.1pp
+20.9pp
-1.5pp
Sector
Own-sector index
—
—
+2.4pp
+2.4pp
+12.2pp
-14.8pp

From atlas_foundation.technical_daily. Sector row covers 1M–12M (1D/1W not stored).

Trend

Price · EMA 20 / 50 / 200

HCG daily close with the three trend EMAs · atlas_foundation.ohlcv_stock.

₹ (close)
687.90-12.30

Relative strength

RS vs baseline · rebased to 100

HCG ÷ Nifty 500, rebased to 100 at window start — above 100 = outperforming since then.

RS vs Nifty 500 (=100)
174.46-2.37

TradingView composite technical analysis — multi-timeframe consensus

Quarterly financials

Last 8 quarters from the company’s filings (₹ crore) — revenue, profit, margins and the growth trend.

MetricJun '24Sep '24Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26
Revenue (₹cr)526554558585613647633652
↳ change QoQ—+5.3%+0.7%+5.0%+4.8%+5.5%-2.1%+3.0%
EBITDA (₹cr)10011393106108123110125
EBITDA margin19.0%20.5%16.7%18.1%17.6%19.1%17.3%19.2%
PAT (₹cr)142187621-84
↳ change QoQ—+51.7%-62.5%-12.6%-11.7%+245.5%-138.2%+151.1%
Net margin2.6%3.7%1.4%1.2%1.0%3.2%-1.3%0.6%
EPS (₹)0.871.290.500.500.321.09-0.630.15
D/E————————
YoY growth · Mar '26Revenue +11.5% YoYPAT -40.3% YoY

Corporate announcements

Filings to the exchange — capital actions, earnings and governance. Most recent first.

  • 9 Sep '26
    LOWgovernance
    Options to purchase securities
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 28 Aug '26
    LOWgovernance
    General Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 27 Aug '26
    LOWgovernance
    Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 10 Aug '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 7 Aug '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 7 Aug '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 6 Aug '26
    MEDIUMcapital
    Press Release
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 6 Aug '26
    MEDIUMearnings
    Investor Presentation
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 6 Aug '26
    LOWgovernance
    Monitoring Agency Report
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 6 Aug '26
    LOWgovernance
    Statement of deviation(s) or variation(s) under Reg. 32
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 6 Aug '26
    MEDIUMgovernance
    Appointment
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 6 Aug '26
    LOWgovernance
    General Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 6 Aug '26
    HIGHearnings
    Outcome of Board Meeting
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 4 Aug '26
    LOWgovernance
    Memorandum of Understanding/Agreements
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 27 Jul '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗

…and 5 more.

Ownership

Who holds HCG

Mutual funds holding HCG (10)

FundWeightAUM ₹crGrade
Axis Small Cap Fund Reg Gr0.73%30,089
Nippon India ELSS Tax Saver Gr1.67%14,910
Nippon India ELSS Tax Saver DirGr1.67%14,910
Franklin India Small Cap Gr0.82%14,467
Axis Flexi Cap Reg Gr0.79%13,478
SBI Healthcare Opportunities Reg Gr0.73%5,400
Tata ELSS Reg Gr1.04%4,664
Tata Aggressive Hybrid Reg Gr1.71%3,930
Tata Flexi Cap Reg Gr0.86%3,705
Bandhan Midcap Reg Gr0.60%2,403

ETFs holding HCG (1)

ETFWeightGrade
Groww BSE Hospitals ETF1.43%
Show company profile (about, sector, employees, IPO)
Native from atlas_foundation — lens journal, technical_daily, ohlcv_stock; TradingView for the live instrument view. ← Back to Healthcare